Cargando…

Preimplantation genetic testing for familial amyloid polyneuropathy

BACKGROUND: Embryo selection in Familial amyloid polyneuropathy eradicates the disease, but the widespread application of preimplantation genetic testing (PGT) for this monogenic disease still requires greater political and clinical commitment. MAIN BODY: Familial amyloid polyneuropathy is a fatal,...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sousa, Mário
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675164/ https://www.ncbi.nlm.nih.gov/pubmed/36401333 http://dx.doi.org/10.1186/s12978-022-01491-x

Ejemplares similares

Psychopathological dimensions in familial amyloid polyneuropathy patients
por: Lopes, Alice, et al.
Publicado: (2015)

The rehabilitation in the management of Transthyretin Familial Amyloid Polyneuropathy
por: Morier, Agnès, et al.
Publicado: (2015)

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria
por: Sarafov, Stayko, et al.
Publicado: (2015)

Clinical and genetic features of transthyretin-related familial amyloid polyneuropathy in China
por: Liu, Lei, et al.
Publicado: (2020)

Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy
por: Lopes, Alice, et al.
Publicado: (2017)

Familial Amyloid Polyneuropathy Misdiagnosed as Systemic Sclerosis
por: Pereira, Márcia Agostinho, et al.
Publicado: (2022)

Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal
por: Inês, Mónica, et al.
Publicado: (2015)

Inflammatory profiling of patients with familial amyloid polyneuropathy
por: Azevedo, Estefania P., et al.
Publicado: (2019)

Clinical, epidemiological, genetic, and electrophysiological characteristics of transthyretin familial amyloid polyneuropathies in Israel
por: Sadeh, Menachem, et al.
Publicado: (2015)

Familial amyloid polyneuropathy in Portugal: New genes modulating age‐at‐onset
por: Santos, Diana, et al.
Publicado: (2016)

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
por: Rousseau, Antoine, et al.
Publicado: (2015)

Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy
por: Collins, Michael, et al.
Publicado: (2018)

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy
por: Schmidt, Hartmut H., et al.
Publicado: (2018)

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)
por: Bolte, Fabian J., et al.
Publicado: (2020)

Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy
por: Du, Kang, et al.
Publicado: (2021)

Commentary on two recently published formal guidelines on management of “mosaic” embryos after preimplantation genetic testing for aneuploidy (PGT-A)
por: Gleicher, Norbert, et al.
Publicado: (2021)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy
por: Koike, Haruki, et al.
Publicado: (2015)

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

“Red‐flag” symptom clusters in transthyretin familial amyloid polyneuropathy
por: Conceição, Isabel, et al.
Publicado: (2016)

Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy
por: Schmidt, Hartmut H.‐J., et al.
Publicado: (2016)

Non-invasive preimplantation genetic testing: a literature review
por: Sousa, Larissa Nogueira, et al.
Publicado: (2022)

Preimplantation Genetic Testing for Monogenic Disorders
por: De Rycke, Martine, et al.
Publicado: (2020)

Preimplantation Genetic Testing for Breast Cancer
por: Oribamise, Eunice I., et al.
Publicado: (2019)

Utilization of preimplantation genetic testing in the USA
por: Roche, Kaitlyn, et al.
Publicado: (2021)

The hidden story behind gender differences in familial amyloid polyneuropathy (FAP) ATTRV30M
por: Santos, Diana, et al.
Publicado: (2015)

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
por: Coelho, Teresa, et al.
Publicado: (2013)

Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France
por: Mariani, Louise‐Laure, et al.
Publicado: (2015)

Transthyretin familial amyloid polyneuropathy impact on health-related quality of life
por: Inês, Mónica, et al.
Publicado: (2015)

The Temporal Profiles of Changes in Nerve Excitability Indices in Familial Amyloid Polyneuropathy
por: Lai, Hsing-Jung, et al.
Publicado: (2015)

Transthyretin familial amyloid polyneuropathy (TTR‐FAP): Parameters for early diagnosis
por: Escolano‐Lozano, Fabiola, et al.
Publicado: (2017)

Clinical and laboratory test in patients with familial amyloid polyneuropathy: differences between symptomatic patients and asymptomatic carriers
por: Raya-Cruz, Manuel, et al.
Publicado: (2015)

C1QA and C1QC modify age‐at‐onset in familial amyloid polyneuropathy patients
por: Dias, Andreia, et al.
Publicado: (2019)

Preimplantation genetic testing for aneuploidies screening is not diagnostic
por: Barad, David H.
Publicado: (2022)

Preimplantation Genetic Testing: Where We Are Today
por: Greco, Ermanno, et al.
Publicado: (2020)

The status of preimplantation genetic testing in the UK and USA
por: Theobald, Rachel, et al.
Publicado: (2020)

Preimplantation genetics
Publicado: (1991)

A variant of prealbumin from amyloid fibrils in familial polyneuropathy of Jewish origin
Publicado: (1981)

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy
por: Adams, David, et al.
Publicado: (2016)

In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography
por: Kollmer, Jennifer, et al.
Publicado: (2015)

Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
por: Suenaga, Genki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a61aonf539lljifos0mg2u3qj3